Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2

Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2

US Patent 8614183 · Granted Dec 24, 2013

Estimated economic value: $4,956,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of making afucosylated anti-FGFR2IIIB antibodies2025
Afucosylated anti-FGFR2IIIB antibodies2022
Methods of treating lung cancer2020
Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb a2019
Process for laying fibrous webs from a centrifugal spinning process2018
Process for laying fibrous webs from a centrifugal spinning process2017
Method of treatment of cancers characterized by ligand-dependent activating muta2015
Method of treatment of cancers characterized by ligand-dependent activating muta2015
Method of treating coronary artery disease by administering FGF-92015
Hair growth methods using FGFR3 extracellular domains2014
Method of treating coronary artery disease by administering FGF-52013
Method of promoting hair growth using FGFR4 extracellular domains2013